Security Snapshot

TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) Institutional Ownership

CUSIP: 872381108

13F Institutional Holders and Ownership History from Q4 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

34

Shares (Excl. Options)

26,775,305

Price

$0.62

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-633,037
Value change
-$516,766
Number of holders
34
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
44,774,864
SEC-reported price per share
$0.96
Insider filing price
$0.96
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 872381108.
  • 34 institutions reported positions in Q1 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 41 to 34 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $32,498,316 to $16,599,743.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 34 institutions filings for Q1 2026.

Open SEC evidence

Security key

872381108

Latest holder period

Q1 2026

13F holders

34

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
TELA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EW HEALTHCARE PARTNERS FUND 2, L.P. 17% -0.53% $7,406,121 7,714,709 0% EW Healthcare Partners Fund 2-GP, L.P. 09 Jun 2026
Nantahala Capital Management, LLC 13% +29% $4,804,893 +$1,069,026 5,111,588 +29% Nantahala Capital Management, LLC 30 Apr 2025
NORTH RUN CAPITAL, LP 9.3% +86% $3,608,839 +$1,666,000 3,682,489 +86% North Run Capital, LP 31 Mar 2025
SILVERARC CAPITAL MANAGEMENT, LLC 7.8% $2,881,710 3,065,649 SilverArc Capital Management, LLC 31 Dec 2024
LYTTON LAURENCE W 5.5% -24% $1,465,405 -$253,778 2,442,341 -15% Lytton, Laurence W. 31 Mar 2026
Stonepine Capital Management, LLC 6% $2,211,913 2,353,099 Stonepine Capital Management, LLC 31 Dec 2024
HIRSCHMAN ORIN 3.6% -46% $1,331,344 -$1,171,674 1,416,323 -47% Orin Hirschman 31 Mar 2025

As of 31 Mar 2026, 34 institutional investors reported holding 26,775,305 shares of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA). This represents 60% of the company’s total 44,774,864 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
60%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Essex Woodlands Management, Inc. 17% 7,714,709 0% 1.9% $4,783,120
Nantahala Capital Management, LLC 11% 5,144,114 +0.64% 0.2% $3,189,351
Stonepine Capital Management, LLC 5.8% 2,617,252 +11% 1.4% $1,622,696
SILVERARC CAPITAL MANAGEMENT, LLC 5% 2,259,312 -15% 0.17% $1,400,773
VANGUARD CAPITAL MANAGEMENT LLC 3.4% 1,540,624 0% 0% $955,187
DAFNA Capital Management LLC 3.2% 1,441,029 0% 0.2% $893,438
PERKINS CAPITAL MANAGEMENT INC 3.2% 1,418,328 +1.5% 0.82% $879,363
UBS Group AG 2.4% 1,059,524 -29% 0% $656,905
CITIGROUP INC 1.7% 750,000 0% 0% $465,000
Sio Capital Management, LLC 1.4% 636,300 0% 0.06% $394,506
BlackRock, Inc. 1% 465,814 +0.75% 0% $288,805
GEODE CAPITAL MANAGEMENT, LLC 1% 455,059 +26% 0% $282,164
WealthTrust Axiom LLC 0.84% 376,938 +17% 0.06% $233,701
VANGUARD FIDUCIARY TRUST CO 0.47% 211,662 0% 0% $131,230
NORTHERN TRUST CORP 0.39% 174,398 0% 0% $108,127
Embree Financial Group 0.26% 118,178 +6.2% 0.01% $73,271
STATE STREET CORP 0.14% 63,383 0% 0% $39,297
PNC FINANCIAL SERVICES GROUP, INC. 0.12% 53,612 0% 0% $33,239
RENAISSANCE TECHNOLOGIES LLC 0.12% 52,600 -59% 0% $32,612
Destiny Wealth Partners, LLC 0.12% 52,500 0% 0% $32,550
RAYMOND JAMES FINANCIAL INC 0.11% 49,700 +65% 0% $30,814
Ducere Wealth Management LLC 0.09% 41,000 +105% 0.01% $25,420
ACADIAN ASSET MANAGEMENT LLC 0.05% 20,817 0% 0% $12,000
GREAT VALLEY ADVISOR GROUP, INC. 0.04% 19,703 +0.52% 0% $12,153
XTX Topco Ltd 0.03% 15,173 -63% 0% $9,407

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
26
Latest
Q1 2026
Rows shown
1-25 of 26
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 26,775,305 $16,599,743 -$516,766 $0.62 34
2025 Q4 27,581,886 $32,498,316 +$4,151,171 $1.18 41
2025 Q3 23,562,953 $35,108,965 +$70,979 $1.49 40
2025 Q2 23,475,441 $45,542,765 -$775,817 $1.94 45
2025 Q1 24,589,431 $30,000,578 -$5,393,768 $1.22 47
2024 Q4 27,032,996 $81,640,185 +$27,788,571 $3.02 46
2024 Q3 18,012,190 $45,588,967 -$10,956,793 $2.53 48
2024 Q2 19,879,104 $93,430,843 -$6,702,626 $4.70 67
2024 Q1 20,686,484 $117,292,014 -$1,655,166 $5.67 58
2023 Q4 20,961,753 $138,767,513 -$8,011,684 $6.62 59
2023 Q3 21,852,278 $174,816,904 -$1,837,658 $8.00 66
2023 Q2 22,055,151 $223,420,734 +$51,494,354 $10.13 67
2023 Q1 16,939,491 $180,199,912 -$5,749,423 $10.64 54
2022 Q4 17,430,212 $200,446,271 +$6,246,137 $11.50 49
2022 Q3 16,786,563 $143,023,324 +$28,855,257 $8.52 43
2022 Q2 13,534,368 $95,028,004 +$13,917,248 $7.01 31
2022 Q1 11,160,859 $129,798,000 +$6,753,935 $11.63 29
2021 Q4 10,531,506 $134,807,000 -$160,970 $12.80 34
2021 Q3 10,239,091 $139,838,000 -$320,790 $13.66 35
2021 Q2 10,239,149 $164,948,850 +$6,022,396 $16.11 43
2021 Q1 9,891,266 $147,387,000 +$2,988,786 $14.90 46
2020 Q4 9,690,658 $145,766,000 -$988,972 $15.04 47
2020 Q3 9,752,756 $161,293,000 +$2,115,756 $16.54 43
2020 Q2 9,735,757 $126,197,000 +$43,684,111 $12.96 49
2020 Q1 6,476,845 $50,649,000 -$2,643,965 $7.82 26
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .